Deals & IPOs

Elligint Health Buys Laguna Health, Adding Conversational AI

Elligint Health acquires Laguna Health, adding AI that documents member conversations with 99% clinical accuracy to Helios, which covers over 13 million lives in all 50 states.

By Amara Osei

3 min read

Elligint Health: Acquisition Of Laguna Health Adds Conversational AI To Care Management Platform
Elligint Health: Acquisition Of Laguna Health Adds Conversational AI To Care Management PlatformStockSnap / pixabay

What's News

  • Elligint Health acquired conversational AI maker Laguna Health; terms undisclosed.
  • Laguna's AI documents member conversations with 99% clinical content accuracy.
  • Helios supports care and utilization management workflows covering 13+ million lives across all 50 states.
  • A multistate health plan case study reported a 66% reduction in documentation time.
  • Laguna Insight was named one of TIME's Best Inventions of 2024.

Elligint Health has acquired Laguna Health, a conversational AI company whose tools document member conversations with 99% clinical content accuracy, and will pair the technology with its Helios care management platform serving workflows covering more than 13 million lives across all 50 states.

Elligint Health, which supplies care management and utilization management technology to U.S. health plans and risk-bearing organizations, announced the deal without disclosing terms. Laguna Health will keep operating as a wholly owned subsidiary, retaining its brand, products and website. Co-founder Yoni Shtein stays on as CEO of the business.

The transaction targets a persistent pain point for insurers: administrative burden. Elligint says the combination will help health plans cut paperwork, improve quality oversight and free care teams to spend more time with members.

What does Laguna bring to Helios?

Laguna, founded in 2020 by Shtein and Yael Peled Adam, sells three products. Laguna Companion is an AI copilot that helps care managers prepare for member calls, assists during conversations and automates documentation afterward. Laguna Insight analyzes member conversations against health plans' clinical standards and operating protocols — reviewing every call rather than a sample, and earning a spot on TIME's Best Inventions of 2024 list. LISA is an agentic AI assistant that handles autonomous member outreach, assessments and handoffs to human care teams.

The performance claims are specific. A published customer case study involving a multistate health plan reported a 66% reduction in documentation time. Laguna also cited a peer-reviewed randomized controlled trial published in the Journal of Healthcare Management supporting its approach. The company notes outcomes may differ across health plans and deployment environments.

"Health plans want AI that helps care teams in their daily work, and they want proof that it's accurate and safe. Laguna has that proof today," said Chris Caramanico, CEO of Elligint Health. "It's a safe, low-risk, high-return use of AI, proven with health plans. It works inside the systems plans already use, and each plan stays in full control, with Laguna configured to its own workflows and protocols. Helios runs the work. Laguna makes every conversation count. Together, we can bring AI into care management faster than either company could alone."

How will the integration work?

Elligint will make Laguna's technology available both independently and through Helios. Health plans can deploy Laguna products inside their existing care management systems without requiring an integration before initial use. Over time, Elligint plans to tie Laguna's AI more closely to Helios, starting with Laguna Companion. Customers will keep working with their existing teams as the integration progresses.

Shtein framed the deal as scale plus continuity. "Our customers chose Laguna because it gives care managers time back with members and gives leaders a clear view of every conversation. Elligint shares our belief that AI should support care managers, not replace them," he said. "With Elligint Health's reach across health plans, we can bring Laguna to many more care teams, and our customers keep the product, team and brand they know."

Who is behind Laguna?

Laguna Health maintains offices in Edison, New Jersey, and Tel Aviv. Its institutional investors have included Pitango HealthTech, LionBird, A-Squared Ventures, HC9 Ventures and SemperVirens.

The acquisition broadens Elligint's technology ecosystem, which spans Helios, advanced analytics and partner solutions. By folding in Laguna's conversational AI, Elligint positions its platform to support more stages of the care management process — from initial member outreach through documentation and quality assessment — with Caramanico emphasizing deployment inside established workflows and clinical protocols rather than around them.

Source: pulse2.com

Share this article:

More from Amara Osei

Amara Osei

Show full bio

Senior reporter covering companies, deals and strategy in entrepreneurship, startups and venture funding at Business Bearings.

2,136 articles

Related articles

« Previous articleNext article »